Getty Images
Treating primary bone cancers is a taxing process that involves antiquated chemo cocktails and limb amputation, but a new study could change the way we treat them. A recent News Medical article discussed a new drug called PTC596 that has shown promise in treating different types of primary bone cancer. Primary bone cancers are rare and affect mostly children and young adults, with current treatment options often limited to surgery and chemotherapy.
